Skip to main content

ANBL1232 Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma

NCT02176967

Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma

Associated Conditions

Brain Cancer

Principal Investigator

Sponsor

Children's Oncology Group

The overall goal for all subjects in this study is: Based on group assignment, we want to see if we can treat non-high-risk NBL by either not doing surgery or by changing the amount of chemotherapy given and still get very good results.

This study is currently enrolling.